Dosing of Aminoglycosides in Chronic Kidney Disease and End-Stage Renal Disease Patients Treated with Intermittent Hemodialysis

• Asıl Yazarlar: Barbora Agatha Halouzková (Yazar), Jan Miroslav Hartinger (Yazar), Vojtěch Krátký (Yazar), Vladimír Tesař (Yazar), Ondřej Slanař (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Karger Publishers, 2022-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: The dosing of aminoglycosides (AGs) in patients with kidney disease is challenging due to their markedly prolonged half-life, which renders pulse dosing schedules unsuitable. We performed a review of the literature that describes the pharmacokinetics of, and dosing recommendations for, A...